BioMark has recently completed a very encouraging metabolome study that has implication for biomarker signature related to cancer diagnosis. The discovery is being patented.
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
BioMark’s Liquid Biopsy Platform Takes A Major Step Forward in Breast Cancer Diagnosis with AI-powered
Form 7 Monthly Progress Report December 2024 Name of Listed Issuer: Trading Symbol: Number of
BioMark Expands its Liquid Biopsy Platform with two Groundbreaking Publications in Breast Cancer Detection BioMark
Form 7 Monthly Progress Report November 2024 Name of Listed Issuer: Trading Symbol: Number of
Form 7 Monthly Progress Report October 2024 Name of Listed Issuer: Trading Symbol: Number of
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2